Item(by='lhl', descendants=None, kids=None, score=None, time=1602618267, title=None, item_type='comment', url=None, parent=24768721, text='While I&#x27;m a big fan of Vitamin D in general, one thing to watch out for is that while this paper cites meta-analysis of associations of <i></i>serum levels<i></i> of 25(OH)D and ACM as an argument for supplementation:<p>Garland, Cedric F., June Jiwon Kim, Sharif Burgette Mohr, Edward Doerr Gorham, William B. Grant, Edward L. Giovannucci, Leo Baggerly, et al. “Meta-Analysis of All-Cause Mortality According to Serum 25-Hydroxyvitamin D.” American Journal of Public Health 104, no. 8 (August 2014): e43–50. <a href="https:&#x2F;&#x2F;doi.org&#x2F;10.2105&#x2F;AJPH.2014.302034" rel="nofollow">https:&#x2F;&#x2F;doi.org&#x2F;10.2105&#x2F;AJPH.2014.302034</a>.<p>Recent meta-analysis seems to suggest that <i></i>supplementation<i></i> is <i></i>not<i></i> associated with lower ACM. In that case, Vitamin D would be primarily a marker for poor outcomes, not the actual primary cause.<p>n=75,454 &quot;Vitamin D supplementation alone was not associated with all cause mortality in adults compared with placebo or no treatment. Vitamin D supplementation reduced the risk of cancer death by 16%. Additional large clinical studies are needed to determine whether vitamin D3 supplementation is associated with lower all cause mortality.&quot;<p>Zhang, Yu, Fang Fang, Jingjing Tang, Lu Jia, Yuning Feng, Ping Xu, and Andrew Faramand. “Association between Vitamin D Supplementation and Mortality: Systematic Review and Meta-Analysis.” BMJ 366 (August 12, 2019): l4673. <a href="https:&#x2F;&#x2F;doi.org&#x2F;10.1136&#x2F;bmj.l4673" rel="nofollow">https:&#x2F;&#x2F;doi.org&#x2F;10.1136&#x2F;bmj.l4673</a>.<p>2011 Discussion on Vitamin D as a marker:<p>Jacobs, Elizabeth T., María Elena Martínez, and Peter W. Jurutka. “Vitamin D: Marker or Mechanism of Action?” Cancer Epidemiology, Biomarkers &amp; Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 20, no. 4 (April 2011): 585–90. <a href="https:&#x2F;&#x2F;doi.org&#x2F;10.1158&#x2F;1055-9965.EPI-10-1257" rel="nofollow">https:&#x2F;&#x2F;doi.org&#x2F;10.1158&#x2F;1055-9965.EPI-10-1257</a>.')